The Wolverine Stack pairs BPC-157 (Body Protection Compound-157) with TB-500, a synthetic fragment of Thymosin Beta-4, for complementary tissue repair research.

The Wolverine Stack pairs BPC-157 (Body Protection Compound-157) with TB-500, a synthetic fragment of Thymosin Beta-4, for complementary tissue repair research. BPC-157 drives localized angiogenesis, growth factor signaling, and healing of tendons, ligaments, muscles, and gut tissue. TB-500 supports systemic cell migration via actin regulation, reduces inflammation, and promotes new blood vessel formation. This BPC-157 TB-500 combination targets non-overlapping pathways, making it popular in preclinical studies for accelerated soft-tissue recovery. Available as separate peptides or pre-blended research vials, the Wolverine peptide stack is not FDA-approved and relies mainly on animal data with limited human evidence. Used strictly for laboratory investigation of regenerative protocols.